EcoDrugPlus

Ensembl ID : ENSLBEG00000017334
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSLBEG00000026781
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSLBEG00000016482
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSLBEG00000016419
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSLBEG00000003591
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSLBEG00000016179
Gene Symbol: -
Cross references: -
891 Possible Orthologues:

Ensembl ID : ENSLBEG00000027406
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSLBEG00000016164
Gene Symbol: -
Cross references: -
908 Possible Orthologues:

Ensembl ID : ENSLBEG00000004984
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSLBEG00000014396
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSLBEG00000014206
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSLBEG00000004962
Gene Symbol: -
Cross references: -
227 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).